Taylor Ian
- SEC CIK
- 0001753281
No open-market purchases or sales filed in the past year.
Current role at each company
- ARVN Arvinas, Inc.President, R&Das of Feb 25, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Taylor Ian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2025 (view filing) | Feb 24 | 1 day | Taylor IanPresident, R&D | SSale | −9.02K | $16.71 | −$150.8K | −5.4%159.1K after | 2 lots |
| Feb 27, 2024 (view filing) | Feb 23 | 4 days | Taylor IanChief Scientific Officer | SSale | −1.70K | $47.05 | −$80.0K | −1.1%147.5K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Taylor IanChief Scientific Officer | SSale | −1.05K | $29.53 | −$31.0K | −1.0%101.7K after | |
| Mar 4, 2022 (view filing) | Mar 4 | Same day | Taylor IanChief Scientific Officer | SSale | −869 | $63.94 | −$55.6K | −1.0%84.0K after | |
| Feb 17, 2022 (view filing) | Feb 15 | 2 days | Taylor IanChief Scientific Officer | SSale | −20.0K | $73.02 | −$1.46M | −20.3%78.6K after | 6 lots |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Taylor IanChief Scientific Officer | SSale | −20.0K | $84.04 | −$1.68M | −20.3%78.6K after | 3 lots |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Taylor IanChief Scientific Officer | SSale | −20.0K | $87.30 | −$1.75M | −20.3%78.6K after | 3 lots |